In gallbladder carcinoma, miR-30b inhibits the proliferation, metastasis, and invasion of cancer cells by targeting ecto-5′-nucleotidase (NT5E) [22] and proline-rich transmembrane protein 2 (PRRT2) [23]. This evidence concerns the gene PRRT2 and cancer.